Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

NCT01680640 - Bifidobacterium animalis lactis BB-12 + Fructooligosaccharides (FOS) & Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Dysbiosis might contribute to the development of non-alcoholic fatty liver disease (NAFLD), and using a synbiotic, which combines a probiotic and prebiotic, could be advantageous
Scorletti et al. 2020 Gastroenterology 158(6): 1597-1610

NCT01680640 - Bifidobacterium animalis lactis BB-12 + Fructooligosaccharides (FOS) vs Maltodextrin & Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD) is a randomized…

Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease
Scorletti et al. 2020 Gastroenterology 158(6): 1597-1610

7/1/2026